Cardiogeni PLC (OFEX: CGNI)
Health Care · Biotechnology · GB
£0.07
-6.67% today · -6.7% 1Y
Cardiogeni PLC (OFEX: CGNI) operates in the Biotechnology industry within the Health Care sector. The company is valued at $9.12M.
Over the last twelve months the share price has lost 6.7%.
Tweenvest scores Cardiogeni PLC across four factors: value 55/100. Its strongest factor is value.
CGNI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.12M
- Revenue (TTM)
- $10.07M
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- £—
- 52-week low
- £—
- Avg volume (3M)
- —
- Shares outstanding
- 96.15M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $467.44B | $265.79 | +0.48% |
| Amgen Inc.NasdaqGS: AMGN | $239.95B | $442.24 | -0.36% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.95B | $148.77 | +1.38% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.79B | $552.85 | +0.96% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $82.73B | $833.56 | +0.61% |
| argenx SEENXTBR: ARGX | $63.06B | €879.20 | +1.74% |
| CSL LimitedASX: CSL | $57.94B | AU$169.11 | +0.48% |
| Moderna, Inc.NasdaqGS: MRNA | $55.45B | $158.83 | +14.36% |
Figures last refreshed Aug 18, 2026.